Miami
BD Biosciences is building the AF2 (Animal-Free/Antibiotic-Free) bioprocess manufacturing facility in Miami. The 90,000-sf cGMP production plant is expected to open in October of 2009 and will manufacture products monitored for animal-origin component raw materials to the tertiary level. The project will include cell culture operations and large-scale liquid filling equipment, supporting the needs of bioprocess companies working with mammalian, microbial, or stem cell lines.
